Quidel Reports Second Quarter 2016 Financial Results
July 27, 2016 16:10 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - July 27, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Hold Second Quarter 2016 Financial Results Conference Call on July 27, 2016
July 13, 2016 15:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - July 13, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
Quidel to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
April 28, 2016 16:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - April 28, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Quidel Reports First Quarter 2016 Financial Results
April 27, 2016 16:10 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - April 27, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Quidel to Hold First Quarter 2016 Financial Results Conference Call on April 27, 2016
April 12, 2016 16:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - April 12, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Quidel Reports Fourth Quarter and Full Year 2015 Financial Results
February 17, 2016 16:10 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - February 17, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Quidel to Hold Fourth Quarter and Full Year 2015 Financial Results Conference Call on February 17, 2016
February 03, 2016 16:30 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - February 03, 2016) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic...
Quidel Receives CE Mark for Its New Sofia(R) Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis
January 25, 2016 17:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - January 25, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Quidel Announces Preliminary Revenue for Fourth Quarter 2015
January 07, 2016 18:37 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - January 07, 2016) -
Quidel Corporation
(NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular...
Charlie Slacik Joins Quidel's Board of Directors
November 17, 2015 17:00 ET
|
Quidel
SAN DIEGO, CA--(Marketwired - November 17, 2015) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic...